Cerebrospinal neuropeptide Y and substance P in suicide attempters during long-term antidepressant treatment

被引:18
作者
Olsson, A
Regnéll, G
Träskman-Bendz, L
Ekman, R
Westrin, Å
机构
[1] Univ Lund Hosp, Dept Clin Neurosci, Div Psychiat, S-22185 Lund, Sweden
[2] Gothenburg Univ, Dept Psychiat & Neurochem, Inst Clin Neurosci, Gothenburg, Sweden
关键词
neuropeptide Y; substance P; cerebrospinal fluid; antidepressants; suicidal behaviour;
D O I
10.1016/j.euroneuro.2004.01.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This study describes cerebrospinal fluid (CSF), neuropeptide Y (NPY) and substance P (SP) in patients with a recent suicide attempt and during antidepressant treatment. Seven out of 13 patients received antidepressants. The patients were examined on three separate occasions, i.e. at pre-treatment, followed by every 3 or 4 months. Antidepressant treatment seemed to affect the levels of CSF NPY, which decreased significantly between the second and last lumbar puncture despite no significant changes of clinical scores. When the whole group was taken into consideration, both CSF NPY and SP decreased significantly. At pre-treatment, Brief Scale of Anxiety scores were significantly and negatively correlated to CSF SP and tended to be negatively correlated to CSF NPY There were also significant positive correlations between CSF NPY and SP during the entire study in the whole group, possibly reflecting an inter-relationship between these neuropeptides. (C) 2004 Elsevier B.V. and ECNP. All rights reserved.
引用
收藏
页码:479 / 485
页数:7
相关论文
共 34 条
[1]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[2]   CSF SUBSTANCE-P IMMUNOREACTIVITY IN AFFECTIVE-DISORDERS [J].
BERRETTINI, WH ;
RUBINOW, DR ;
NURNBERGER, JI ;
SIMMONSALLING, S ;
POST, RM ;
GERSHON, ES .
BIOLOGICAL PSYCHIATRY, 1985, 20 (09) :965-970
[3]   CEREBROSPINAL-FLUID NEUROPEPTIDE-Y IN DEPRESSION AND SCHIZOPHRENIA [J].
BERRETTINI, WH ;
DORAN, AR ;
KELSOE, J ;
ROY, A ;
PICKAR, D .
NEUROPSYCHOPHARMACOLOGY, 1987, 1 (01) :81-83
[4]   Substance P serum levels are increased in major depression:: Preliminary results [J].
Bondy, B ;
Baghai, TC ;
Minov, C ;
Schüle, C ;
Schwarz, MJ ;
Zwanzger, P ;
Rupprecht, R ;
Möller, HJ .
BIOLOGICAL PSYCHIATRY, 2003, 53 (06) :538-542
[5]   Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze [J].
Britton, KT ;
Akwa, Y ;
Spina, MG ;
Koob, GF .
PEPTIDES, 2000, 21 (01) :37-44
[6]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF BENZODIAZEPINES IN HUMAN-PLASMA [J].
BRODIE, RR ;
CHASSEAUD, LF ;
TAYLOR, T .
JOURNAL OF CHROMATOGRAPHY, 1978, 150 (02) :361-366
[7]   NEUROPEPTIDES AND CEREBROSPINAL-FLUID [J].
BURBACH, JPH .
ANNALS OF CLINICAL BIOCHEMISTRY, 1982, 19 (JUL) :269-277
[8]   PLASMA-LEVEL MONITORING OF ANTIPSYCHOTIC-DRUGS CLINICAL UTILITY [J].
DAHL, SG .
CLINICAL PHARMACOKINETICS, 1986, 11 (01) :36-61
[9]  
GJERRIS A, 1992, J PSYCHIATR NEUROSCI, V17, P23
[10]   EXCITATION OF NEURONS IN NUCLEUS LOCUS COERULEUS BY SUBSTANCE-P AND RELATED PEPTIDES [J].
GUYENET, PG ;
AGHAJANIAN, GK .
BRAIN RESEARCH, 1977, 136 (01) :178-184